Research ArticleArticle
Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis
Charis F. Meng, Diviya A. Rajesh, Deanna P. Jannat-Khah, Bridget Jivanelli and Vivian P. Bykerk
The Journal of Rheumatology August 2022, jrheum.220152; DOI: https://doi.org/10.3899/jrheum.220152
Charis F. Meng
This research was supported by the Inflammatory Arthritis Center, Hospital for Special Surgery, New York, New York, USA. C.F. Meng MD, V.P. Bykerk, MD, Division of Rheumatology, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. D.A. Rajesh, BA, Division of Rheumatology, Hospital for Special Surgery. D.P. Jannat-Khah, DRPH, MSPH, Division of Rheumatology, Epidemiology and Biostatistics CORE, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. B. Jivanelli, MLIS, Kim Barrett Memorial Library, HSS Education Institute, Hospital for Special Surgery, New York, NY, USA. DPJK declares stock ownership in AstraZeneca, Cytodyn, and Walgreens. VPB declares institutional grants from BMS and Amgen; honoraria or consulting fees from Amgen, BMS, Genzyme, Gilead, Janssen, Pfizer, Sanofi-Aventis, and UCB; support by the National Institutes of Health (NIH; National Institute of Allergy and Infectious Diseases/National Institute of Arthritis and Musculoskeletal and Skin; grants 1UH2AR067691-01 and 11652401) and The Cedar Hill Foundation; and participation on the Data Safety Monitoring Board of NIH Cell Therapies. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.F. Meng, Hospital for Special Surgery, 535 E 70th Street, New York, NY 10021, USA. Email: mengc@hss.edu. Accepted for publication July 27, 2022.
Diviya A. Rajesh
This research was supported by the Inflammatory Arthritis Center, Hospital for Special Surgery, New York, New York, USA. C.F. Meng MD, V.P. Bykerk, MD, Division of Rheumatology, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. D.A. Rajesh, BA, Division of Rheumatology, Hospital for Special Surgery. D.P. Jannat-Khah, DRPH, MSPH, Division of Rheumatology, Epidemiology and Biostatistics CORE, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. B. Jivanelli, MLIS, Kim Barrett Memorial Library, HSS Education Institute, Hospital for Special Surgery, New York, NY, USA. DPJK declares stock ownership in AstraZeneca, Cytodyn, and Walgreens. VPB declares institutional grants from BMS and Amgen; honoraria or consulting fees from Amgen, BMS, Genzyme, Gilead, Janssen, Pfizer, Sanofi-Aventis, and UCB; support by the National Institutes of Health (NIH; National Institute of Allergy and Infectious Diseases/National Institute of Arthritis and Musculoskeletal and Skin; grants 1UH2AR067691-01 and 11652401) and The Cedar Hill Foundation; and participation on the Data Safety Monitoring Board of NIH Cell Therapies. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.F. Meng, Hospital for Special Surgery, 535 E 70th Street, New York, NY 10021, USA. Email: mengc@hss.edu. Accepted for publication July 27, 2022.
Deanna P. Jannat-Khah
This research was supported by the Inflammatory Arthritis Center, Hospital for Special Surgery, New York, New York, USA. C.F. Meng MD, V.P. Bykerk, MD, Division of Rheumatology, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. D.A. Rajesh, BA, Division of Rheumatology, Hospital for Special Surgery. D.P. Jannat-Khah, DRPH, MSPH, Division of Rheumatology, Epidemiology and Biostatistics CORE, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. B. Jivanelli, MLIS, Kim Barrett Memorial Library, HSS Education Institute, Hospital for Special Surgery, New York, NY, USA. DPJK declares stock ownership in AstraZeneca, Cytodyn, and Walgreens. VPB declares institutional grants from BMS and Amgen; honoraria or consulting fees from Amgen, BMS, Genzyme, Gilead, Janssen, Pfizer, Sanofi-Aventis, and UCB; support by the National Institutes of Health (NIH; National Institute of Allergy and Infectious Diseases/National Institute of Arthritis and Musculoskeletal and Skin; grants 1UH2AR067691-01 and 11652401) and The Cedar Hill Foundation; and participation on the Data Safety Monitoring Board of NIH Cell Therapies. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.F. Meng, Hospital for Special Surgery, 535 E 70th Street, New York, NY 10021, USA. Email: mengc@hss.edu. Accepted for publication July 27, 2022.
Bridget Jivanelli
This research was supported by the Inflammatory Arthritis Center, Hospital for Special Surgery, New York, New York, USA. C.F. Meng MD, V.P. Bykerk, MD, Division of Rheumatology, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. D.A. Rajesh, BA, Division of Rheumatology, Hospital for Special Surgery. D.P. Jannat-Khah, DRPH, MSPH, Division of Rheumatology, Epidemiology and Biostatistics CORE, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. B. Jivanelli, MLIS, Kim Barrett Memorial Library, HSS Education Institute, Hospital for Special Surgery, New York, NY, USA. DPJK declares stock ownership in AstraZeneca, Cytodyn, and Walgreens. VPB declares institutional grants from BMS and Amgen; honoraria or consulting fees from Amgen, BMS, Genzyme, Gilead, Janssen, Pfizer, Sanofi-Aventis, and UCB; support by the National Institutes of Health (NIH; National Institute of Allergy and Infectious Diseases/National Institute of Arthritis and Musculoskeletal and Skin; grants 1UH2AR067691-01 and 11652401) and The Cedar Hill Foundation; and participation on the Data Safety Monitoring Board of NIH Cell Therapies. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.F. Meng, Hospital for Special Surgery, 535 E 70th Street, New York, NY 10021, USA. Email: mengc@hss.edu. Accepted for publication July 27, 2022.
Vivian P. Bykerk
This research was supported by the Inflammatory Arthritis Center, Hospital for Special Surgery, New York, New York, USA. C.F. Meng MD, V.P. Bykerk, MD, Division of Rheumatology, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. D.A. Rajesh, BA, Division of Rheumatology, Hospital for Special Surgery. D.P. Jannat-Khah, DRPH, MSPH, Division of Rheumatology, Epidemiology and Biostatistics CORE, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. B. Jivanelli, MLIS, Kim Barrett Memorial Library, HSS Education Institute, Hospital for Special Surgery, New York, NY, USA. DPJK declares stock ownership in AstraZeneca, Cytodyn, and Walgreens. VPB declares institutional grants from BMS and Amgen; honoraria or consulting fees from Amgen, BMS, Genzyme, Gilead, Janssen, Pfizer, Sanofi-Aventis, and UCB; support by the National Institutes of Health (NIH; National Institute of Allergy and Infectious Diseases/National Institute of Arthritis and Musculoskeletal and Skin; grants 1UH2AR067691-01 and 11652401) and The Cedar Hill Foundation; and participation on the Data Safety Monitoring Board of NIH Cell Therapies. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C.F. Meng, Hospital for Special Surgery, 535 E 70th Street, New York, NY 10021, USA. Email: mengc@hss.edu. Accepted for publication July 27, 2022.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis
Charis F. Meng, Diviya A. Rajesh, Deanna P. Jannat-Khah, Bridget Jivanelli, Vivian P. Bykerk
The Journal of Rheumatology Aug 2022, jrheum.220152; DOI: 10.3899/jrheum.220152
Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis
Charis F. Meng, Diviya A. Rajesh, Deanna P. Jannat-Khah, Bridget Jivanelli, Vivian P. Bykerk
The Journal of Rheumatology Aug 2022, jrheum.220152; DOI: 10.3899/jrheum.220152